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Abstract
Dendritic and synapse remodeling are forms of structural plasticity that play a critical role in normal hippocampal function.
Neural cell adhesion molecule (NCAM) and its polysialylated form (PSA-NCAM) participate in neurite outgrowth and synapse
formation and plasticity. However, it remains unclear whether they contribute to dendritic retraction and synaptic
disassembly. Cultured hippocampal neurons exposed to glutamate (5 mM) showed a reduced MAP-2 (+) area in the absence
of neuronal death 24 h after the insult. Concomitantly, synapse loss, revealed by decreased synaptophysin and post-
synaptic density-95 cluster number and area, together with changes in NCAM and PSA-NCAM levels were found. Dendritic
atrophy and PSA-NCAM reduction proved NMDA-receptor dependent. Live-imaging experiments evidenced dendritic
atrophy 4 h after the insult; this effect was preceded by smaller NCAM clusters (1 h) and decreased surface and total PSA-
NCAM levels (3 h). Simultaneously, total NCAM cluster number and area remained unchanged. The subsequent synapse
disassembly (6 h) was accompanied by reductions in total NCAM cluster number and area. A PSA mimetic peptide
prevented both the dendritic atrophy and the subsequent synaptic changes (6 h) but had no effect on the earliest synaptic
remodeling (3 h). Thus, NCAM-synaptic reorganization and PSA-NCAM level decrease precede glutamate-induced dendritic
atrophy, whereas the NCAM level reduction is a delayed event related to synapse loss. Consequently, distinctive stages in
PSA-NCAM/NCAM balance seem to accompany glutamate-induced dendritic atrophy and synapse loss.
Citation: Podesta´ MF, Yam P, Codagnone MG, Uccelli NA, Colman D, et al. (2014) Distinctive PSA-NCAM and NCAM Hallmarks in Glutamate-Induced Dendritic
Atrophy and Synaptic Disassembly. PLoS ONE 9(10): e108921. doi:10.1371/journal.pone.0108921
Editor: Pascale CHAVIS, INSERM U901, France
Received September 5, 2013; Accepted September 5, 2014; Published October 3, 2014
Copyright:  2014 Podesta´ et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants to AR from CONICET (PIP 2010-0937), Agencia National de Promocio´n Cientı´fica y Te´cnica (ANPCYT) PICT 2010-2739
and Universidad de Buenos Aires (UBACYT 2010 and 2012), Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* Email: areines@ffyb.uba.ar
{ Deceased June 1, 2011.
Introduction
Structural plasticity plays a crucial role in normal hippocampal
function. Dendritic and synaptic remodeling in the Cornus
Ammonis (CA) 1 and 3 regions, as well as neurogenesis in the
Dentate Gyrus (DG) are the mechanisms involved in hippocampal
structure reorganization [1,2]. These neuroplastic phenomena
enable hippocampal neurons to modify their synaptic morphology,
which in turn allows them to adapt to new situations or
environmental changes. It is worth noting that, if reorganization
is not adequate, structural remodeling might contribute to nervous
system malfunction [3]. Consequently, deregulation or disruption
of this fundamental process may compromise the normal function
of the hippocampus.
In line with this, dysfunctional hippocampal plasticity has been
repeatedly evidenced in a number of clinical and preclinical
studies. For instance, hippocampal volume reduction is presently
one of the most consistent structural abnormalities found in
schizophrenia, dementia, Alzheimer’s, Parkinson’s, depression and
in other stress-related psychiatric disorders [4–6]. It has been
clearly established that structural changes may affect synapse
function. However, whether structural remodeling should be
prevented or promoted in the aforementioned pathologies remains
a matter of debate, since it may serve to prevent further damage.
In this regard, alterations in somatodendritic, axonal and synaptic
components have been proposed as putative mechanisms under-
lying hippocampal shrinkage [7]. Changes in spine morphology,
dendritic atrophy and synapse loss have also been demonstrated in
a number of the above mentioned disorders [8].
Numerous pieces of evidence strongly associate dendritic
atrophy with the reduction in hippocampal volume, and with
the hippocampal-dependent behavioral deficit characteristic of
psychiatric and neurological disorders [9–12]. Glucocorticoids and
excitatory amino acids are known to participate in this form of
hippocampal structural plasticity [10,13,14]. Several experimental
findings have been presented to account for this; for instance,
stress-induced dendritic atrophy is prevented by NMDA receptor
antagonists [13,15,16] and by the antiepileptic drug phenytoin
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[10], a molecule that also interferes with glutamatergic neuro-
transmission.
Not only are glutamatergic receptors and cytoskeletal proteins
important for synapse structure, stability and function, but also cell
adhesion molecules play a determinant part [17–21]. The neural
cell adhesion molecule (NCAM) is one of the most abundant in
hippocampal excitatory synapses [22,23]. In addition to its role in
synapse adhesion, robust evidence supports an NCAM role during
synaptogenesis, recruiting and stabilizing the vesicular pool
[24,25]. On the other hand, PSA-NCAM (the polysialylated form
of NCAM) has been implicated in neurite growth during
synaptogenesis, synapse remodeling and plasticity [26,27]. Inter-
estingly, remodeling of hippocampal dendritic spines after
polysialic acid (PSA) removal from NCAM has been recently
described [28]. Nevertheless, it remains unclear whether NCAM
and PSA-NCAM participate in dendritic retraction, and if so, to
what extent they contribute to synaptic remodeling and/or
disassembly.
The aim of the present work was thus to investigate the synaptic
and dendritic events that take place during hippocampal dendritic
retraction and atrophy. In particular, we studied whether defects
in synaptic NCAM correlate with dendritic retraction and
atrophy. Finally, we evaluated how synaptic remodeling is related
to dendritic atrophy. As experimental model, we employed an in
vitro approach which consisted of exposing cultured hippocampal
neurons, after the synaptogenic peak, to a low glutamate
concentration (5 mM), a strategy that resulted in a reduction of
the dendritic tree area in the absence of neuronal death. It is worth
noting that glutamate can facilitate or inhibit dendrite outgrowth,
an effect that is time and concentration-dependent [29,30]. In this
setting, we studied the temporal course of events related to
synaptic remodeling and dendritic retraction by evaluating the
expression pattern of the pre-synaptic marker synaptophysin
(SYN), the post-synaptic marker post-synaptic density 95 (PSD-
95), and the cell adhesion molecules NCAM and PSA-NCAM.
The temporal course of glutamate-induced dendritic retraction
was studied in fixed cells as the area of MAP-2 positive structures




Experiments were carried out in accordance with the Guide for
the Care and Use of Laboratory Animals provided by the NIH,
USA. The experimental protocols were approved by the Ethics
Committee for the Care and Use of Laboratory Animals of the
School of Pharmacy and Biochemistry at the University of Buenos
Aires (Approval Number: 220312-1). Special care was taken to
minimize the number and suffering of the animals used.
Animals and drugs
Adult Wistar rats (Facultad de Ciencias Exactas y Naturales,
UBA) weighing 200–230 g at the beginning of the experiments
were used. Animals were housed in groups of four in an air-
conditioned room (temperature: 2062uC) and maintained on a
12–12 h light/dark cycle. Food and water were available ad
libitum.
All chemicals used were of analytical grade. Mouse monoclonal
anti-NCAM (5B8) and anti-PSA-NCAM (5A5) were purchased
from Hybridoma Bank (Iowa, USA). Mouse monoclonal anti-
microtubule-associated protein 2 (MAP-2, Sigma Chemical Co.),
anti-SYN (Chemicom), anti-PSD-95 (Affinity BioReangents Inc.),
and secondary antibodies (FITC- and Red-labeled) (Jackson
InmunoReasearch Laboratory Inc.) were used. Vectashield mount-
ing medium was provided from Vector Laboratory Inc. All reagents
used in culture including CellTracker Green CMFDA (5-chlor-
omethyl fluorescein diacetate) were purchased from Invitrogen.
Functional PSA mimetic peptide (fPSA, H- NTHTDPYIYPID-
OH) was purchased from PB-L Products (University of Quilmes,
Argentina). MK-801, or dizocilpine (5S,10R-(+)-5-Methyl-10,11-
dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine maleate), 6-cya-
no-7-nitroquinoxaline-2,3-dione (CNQX) and Lipofectamine were
purchased from Sigma-Aldrich (St Louis, MO, USA).
Primary neuronal cultures and glutamate treatment
Pregnant Wistar rats on embryonic day 17–18 were placed in a
CO2 chamber and then decapitated. The embryos were quickly
removed by caesarean section and the hippocampi dissected and
processed according to previous reports [31]. Hippocampal tissue
was trypsinized, mechanically dissociated and plated on poly-D-
lysine-coated glass coverslips at 86103 cells/cm2. Cells were
maintained for 13–14 days in vitro (DIV) in Neurobasal medium
supplemented with 2% (v/v) B27 and 0.5 mM glutamine. At 12–
13 DIV, neurons were treated with 5 mM glutamate for 3 minutes
at 37uC and media was immediately removed. Cells were washed
with Hank’s balanced salt solution, incubated in supplemented
culture media for the indicated period of time, either 24 h or 1, 3,
6 or 12 h intervals for the time course experiments, and then fixed
as described bellow for immunostaining. Control neurons were
treated with vehicle, washed with Hank’s balanced salt solution
and identically processed and fixed (1, 3, 6, 12 or 24 h) as
described above. In the experiments with glutamate receptor
antagonists, neurons were pre-incubated before glutamate expo-
sure with 10 mM MK-801 or 20 mM CNQX for 15 or 30 min,
respectively. Experiments with fPSA were done according to
previous reports. This PSA mimetic peptide has been shown to
mimic PSA antigenic and biological properties [32–34]. Briefly,
neurons were treated with 10 mM fPSA immediately after the
glutamate treatment and incubated throughout the studied period
(1, 3 or 6 h).
Figure 1. Glutamate exposure reduces MAP-2 immunostaining and induces changes in synaptic markers and cell adhesion
molecule NCAM in the absence of neuronal death. Hippocampal neurons in culture (DIV 12–13) were briefly exposed to 5 mM glutamate and
evaluated 24 h later. (A) Microphotographs of hippocampal neurons in culture immunostained for MAP-2 or visualized by phase contrast microscopy.
Hoechst staining is shown in the upper right inset. (B) Quantification of MAP-2 immunostaining showed reduced dendritic tree area in glutamate-
exposed neurons. (C) Glutamate exposure did not affect neuronal viability, quantified as the number of neurons per field of view (FOV) with normal
Hoechst staining. Microphotographs of hippocampal neurons in culture doubled stained for (D) SYN and NCAM or (E) PSD-95 and PSA-NCAM. (F)
Synaptic puncta number, (G) total synaptic puncta area and (H) individual puncta area were quantified for SYN, PSD-95 and NCAM. (I) Total
immunoreactive area was measured for PSA-NCAM. Glutamate-exposed cultured hippocampal neurons showed decreased puncta number and area
for SYN, PSD-95 and NCAM. Individual puncta area was larger for SYN, unchanged for PSD-95 and smaller for NCAM. PSA-NCAM immunoreactive area
drastically decreased. Results are expressed as mean values (6SEM) of 20-30 neurons or 10 microscope fields (280,000 mm2/FOV) per experimental
condition. ns, non-significant. ## P,0.01 and ### P,0.001 between bars, non-parametric Mann-Whitney test. ** P,0.01 and *** P,0.001 between
bars, Student t test. MAP-2: microtubule-associated protein 2; NCAM: neural cell adhesion molecule; PSA-NCAM: polysialylated form of NCAM; PSD-95:
post-synaptic density 95; SYN: synaptophysin. Scale bars: 50 mm and 100 mm for phase contrast.
doi:10.1371/journal.pone.0108921.g001
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For live-imaging experiments, primary neuronal cultures were
GFP-transfected (pmax-GFP 0.5 mg/ml, Amaxa) at 7 DIV using
lipofectamine or stained with the CellTracker Green CMFDA
(10 mM) 30 min before glutamate exposure. Cultures were also
stimulated with 5 mM glutamate for 3 minutes, washed as
described above and live-imaging recordings started 2 h later.
Immunostaining
Neurons in culture (13–14 DIV) were fixed for 20 min at room
temperature (RT) in 4% (w/v) paraformaldehyde/4% (w/v)
sucrose in PBS solution, pH 7.2. After permeabilization with
0.2% (v/v) Triton X-100 for 10 min at RT and blockade with 5%
(v/v) normal goat serum for 30 min at RT, neurons were
incubated overnight at 4uC with primary monoclonal antibodies
diluted in PBS (NCAM 1:200; PSA-NCAM 1:200; PSD-95 1:200;
SYN 1:300 or MAP-2 1:1000). The following day, cells were
washed and incubated for 1 h at RT with the appropriate
secondary antibodies. Hoechst 33342 (1:2000) was used to stain
the nuclei and determine the number of neurons with preserved
nuclear morphology. Finally, cells were mounted using Vecta-
shield mounting medium (Vector Laboratory Inc).
The cell surface staining was performed on water–ice slurry to
reduce endocytosis, as previously described [31]. Neurons (13–
14DIV) were washed with ice-cold Dulbecco’s PBS (DPBS),
incubated with PSA-NCAM antibody (1:200) diluted in DPBS for
20 min, washed twice with DPBS, and fixed with 2% (w/v)
paraformaldehyde in DPBS. Cells were then transferred to RT,
washed twice with DPBS, incubated with red labeled secondary
antibody for 30 min, washed three times with DPBS, permeabi-
lized with 0.1% (v/v) Triton X-100 for 10 min, blocked, and
immunostained for total NCAM as described above.
Image acquisition
Immunofluorescence images from fixed cultures were captured
employing 510–560 nm, 450–490 nm and 340–380 nm excitation
filters in an Eclipse 50i Nikon epi-fluorescence microscope
equipped with a Nikon DS-5M cooled camera. Images were
taken to maximize dendritic and puncta staining. The analog
images were digitized into an array of 206061920 pixels
corresponding to an area of 3116233 mm of tissue (406 primary
magnification). Morphology of cultured neurons was visualized by
phase contrast microscopy. The analog images were digitized into
an array of 10246768 pixels corresponding to an area of
2546190 mm (206 primary magnification).
In time-lapse experiments and prior to placing the culture dish
(with a glass-bottomed coverslip as base) on the microscope, the
incubation chamber was equilibrated to 37uC and 5% CO2.
Fluorescence images were captured every 5 min during 3 h using
an Olympus Fluoview FV1000 laser scanning confocal microscope
with a 606 PlanApo oil-immersion objective [1.4 numerical
aperture (NA)] on an IX81 inverted microscope. Images of single
optical sections through the neurite plane were acquired with 1.7
digital zoom and a 465 nm excitation Laser. For PSA-NCAM cell
surface evaluation, single optical sections and compression series
(projections) of z-axis optical sections were used.
Microphotograph compositions were prepared using the Adobe
Photoshop CS3 software (Adobe Systems Inc.).
Quantification
Digital image analysis was performed using the Image J
analyzer sofware (NIH). Neuronal viability was quantified as the
number of neurons per field of view (FOV = 280,000 mm2; 206
magnification) with normal Hoechst staining, and expressed as
mean values (6SEM) of 10 microscope fields per experimental
Figure 2. NMDA receptor blockade prevents MAP-2 and PSA-
NCAM reduction induced by glutamate exposure. Hippocampal
neurons in culture (DIV 12–13) were evaluated 24 h after a brief
exposure to 5 mM glutamate in the absence and presence of different
glutamate antagonists. (A) Quantification of MAP-2 and PSA-NCAM
immunostainings showed reduced dendritic tree area and total PSA-
NCAM immunoreactive area in glutamate-exposed neurons, two
findings that were prevented by pre-treatment with 10 mM MK-801.
(B) Reductions in dendritic tree and PSA-NCAM immunoreactive areas
were not prevented by pre-treatment with 20 mM CNQX. MAP-2 and
PSA-NCAM immunoreactive areas are expressed as mean values (6SEM)
of 30 neurons per experimental condition. ns, non-significant; ** P,0.01
between bars, two-way analysis of variance (ANOVA) followed by
Bonferroni test. ns, non-significant; #P,0.05; ##P,0.01 between bars,
one-way ANOVA followed by Bonferroni test. CNQX: 6-cyano-7-
nitroquinoxaline-2,3-dione; MK-801: (5S,10R)-(+)-5-Methyl-10,11-dihy-
dro-5H-dibenzo[a,d]cyclohepten-5,10-imine maleate or dizocilpine;
PSA-NCAM: polysialylated form of NCAM.
doi:10.1371/journal.pone.0108921.g002
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condition. The experiment was repeated at least three times.
Dendritic tree area per neuron was calculated by subtracting the
area corresponding to the immunolabeled soma from the total
MAP-2 immunostaining. The number of puncta, total puncta area
and individual puncta area for SYN, PSD-95 and NCAM were
calculated as previously described [31,35,36]. For PSA-NCAM
immunostaining [26,37], total immunoreactive area per neuron
was calculated.
The number of puncta, total puncta area and individual puncta
area were calculated employing the count particle function of the
ImageJ programme (NIH) according to previous reports [31].
Puncta were defined as any labelled punctum that represents
Figure 3. Glutamate-induced dendritic retraction visualized in CMFDA-stained neurons.(A) Hippocampal neurons in culture (DIV 12–13)
were stained with the CMFDA dye and then briefly exposed to 5 mM glutamate, and live-imaged 2 h later every 5 min for a 3 h-period. (B)
Microphotographs of hippocampal living neurons in culture showing the progressive shortening of CMFDA positive neurites. (C) Quantification of
dendritic shortening over time. Dendritic retraction is shown as percentage (%) of the dendritic length measured 2 h after glutamate exposure.
Dendritic retraction is clearly evident 4 h after glutamate exposure. Results are expressed as mean values (6SEM). * P,0.05 and ** P,0.01 versus
100%, Student t test. Scale bars = 50 and 17 mm as magnification increases.
doi:10.1371/journal.pone.0108921.g003
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clusters of SYN, PSD-95 and NCAM. For that purpose, a range of
gray values (threshold values) was interactively selected to allow
segmentation of the specific signal from the background, and
thereafter did not differ within or across conditions. Thresholds
were slightly adjusted between sections to maximize number of
puncta and minimize the extent of fusion between puncta, but the
values did not differ within or across conditions. Dendritic
retraction was determined in terminal branches of four neurites
per CMFDA-positive neuron, and was expressed as percentage of
dendritic length [(length at 2 h-length at studied time)/length at
2 h6100]. Unless otherwise stated, all parameters are expressed as
mean values (6SEM) of 20–30 neurons per experimental
condition. Each immunostaining assay consisted of 1–2 coverslips
per experimental condition. The experiments were repeated at
least three times.
Statistics analysis
Statistical analyses were performed using the InfoStat software.
Statistical significance was set at P ,0.05. Of the parameters
studied 24 hours after glutamate exposure, dendritic tree area,
SYN puncta number, total SYN puncta area, individual NCAM
puncta area and total PSA-NCAM immunoreactive area were
statistically analysed by non-parametric Mann-Whitney test,
whereas PSD-95 and NCAM puncta number, total PDS-95 and
NCAM puncta area and individual SYN and PDS-95 puncta area
that were analyzed by Student t test. Percentage of dendritic length
was analysed by Student t test. Results from experiments
employing MK-801 or CNQX were respectively analysed by
two-way and one-way analysis of variance (ANOVA) followed by
Bonferroni test. All parameters obtained from the time course
experiments were subjected to non-parametric Mann-Whitney
test.
Results
Dendritic atrophy in the absence of neuronal death
induced by brief exposure to a low glutamate
concentration
Twenty-four hours after a brief exposure to a low glutamate
concentration we found a reduction in the specific dendritic
marker MAP-2 immunostaining (Fig. 1A), which rendered into a
diminished neuronal dendritic tree area (Fig. 1B). However,
glutamate treatment did not affect neuronal viability, as evidenced
by the number of neurons with preserved nuclear morphology
(Fig. 1A inset and C). Phase contrast microphotographs in Fig. 1A
show a discontinuous pattern in the projections of glutamate-
treated neurons in the absence of cytoplasmic vacuolar formation.
Neuronal effects induced by glutamate exposure on
synaptic markers and cell adhesion molecule NCAM
Cultured neurons exposed to glutamate in a condition that
induced dendritic retraction but not cell death showed changes at
the synaptic level 24 h after treatment. Immunostaining for the
pre-synaptic marker SYN was remarkably affected in glutamated-
treated neurons (Fig. 1D). Quantification of SYN puncta number
and area revealed a dramatic decrease (Fig. 1F and G), with a
concomitant increase in SYN individual puncta area (Fig. 1H).
Similar results were found for the post-synaptic marker PSD-95
(Fig. 1E). However, reduction in PSD-95 puncta number and area
(Fig. 1F and G) occurred in the absence of changes in PSD-95
individual puncta area (Fig. 1H).
Interestingly, glutamate-treated neurons exhibited changes in
NCAM immunostaing 24 h after the insult (Fig. 1D). In this case,
reduction in NCAM puncta number and area (Fig. 1F and G) was
accompanied by a decrease in NCAM individual puncta area
(Fig. 1H). Since PSA-NCAM does not form synaptic puncta due
to its non-adhesive properties, only total immunoreactive area
could be measured for this marker 24 h after neuronal exposure to
glutamate, which revealed a pronounced decrease (Fig. 1E and I).
NMDA receptor-dependent MAP-2 and PSA-NCAM
reduction
In order to determine glutamate receptor specificity, neurons
were incubated with the NMDA receptor antagonist MK-801
before glutamate exposure. In agreement with results described in
Figure 4. A continuous projection pattern becomes discontin-
uous after glutamate exposure.(A) GFP-transfected hippocampal
neurons in culture (DIV 12–13) were briefly exposed to 5 mM glutamate
and live-imaged 2 h later every 5 min for a 3 h-period.(B) Micropho-
tographs of hippocampal living neurons in culture show the
progression from a normal continuous pattern into a discontinuous
one. Scale bars = 50 and 13 mm as magnification increases.
doi:10.1371/journal.pone.0108921.g004
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Figure 5. MAP-2 decrease follows the early PSA-NCAM reduction induced by glutamate exposure. Hippocampal neurons in culture (DIV
12–13) were briefly exposed to 5 mM glutamate and evaluated 1, 3, 6 and 12 h later. (A) Microphotographs of hippocampal neurons in culture
doubled stained for MAP-2 and PSA-NCAM. (B) Quantification of total PSA-NCAM area showed decreased levels 3 h after glutamate exposure, which
remained low for the rest of the studied period (3–12 h). (C) Quantification of MAP-2 immunostaining revealed that reduction in MAP-2
immunoreactive area follows PSA-NCAM diminution. MAP-2 and PSA-NCAM immunoreactive areas are expressed as mean values (6SEM) of 20–30
neurons per experimental condition. ns, non-significant; *** P,0.001 between bars, non-parametric Mann-Whitney test. MAP-2: microtubule-
associated protein 2; PSA-NCAM: polysialylated form of NCAM. Scale bars: 50 mm.
doi:10.1371/journal.pone.0108921.g005
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Figure 6. Early surface PSA-NCAM reduction induced by glutamate exposure. Hippocampal neurons in culture (DIV 12–13) were briefly
exposed to 5 mM glutamate and evaluated 1, 3 and 6 h later. (A) Microphotographs of hippocampal neurons in culture doubled stained for surface
PSA-NCAM and total NCAM. (B) Quantification of PSA-NCAM immunoreactive area showed decreased levels at neuronal surface 3 h after glutamate
exposure, which remained low for the rest of the studied period (3–6 h). (C) Quantification of total (puncta plus diffuse staining) NCAM
immunoreactive area revealed a concomitant NCAM reduction 3 h after glutamate treatment. Results are expressed as mean values (6SEM) of 20–30
neurons per experimental condition. * P,0.05, *** P,0.001 between bars, non-parametric Mann-Whitney test. NCAM: neural cell adhesion molecule;
PSA-NCAM: polysialylated form of NCAM. Scale bar: 50 mm.
doi:10.1371/journal.pone.0108921.g006
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Fig. 1, Fig. 2A shows that in the absence of the NMDA receptor
antagonist, exposure to glutamate decreased neuronal dendritic
tree area and reduced total PSA-NCAM immunostaining. Both
glutamate-induced neuronal effects were prevented by MK-801
pre-treatment (Fig. 2A). On the contrary, reduction in the
neuronal dendritic tree area and PSA-NCAM immunostaining
was not prevented by pre-incubation with the AMPA receptor
antagonist CNQX (Fig. 2B).
Glutamate-dependent dendritic retraction and atrophy
are relatively fast phenomena
To accurately define the temporal course of glutamate-induced
dendritic retraction and atrophy, time-lapse experiments employ-
ing cytoplasmic markers were carried out.
Glutamate-treated neurons previously filled up with the
CMFDA dye showed a significant dendritic length decrease as
early as 4 h after the insult (Fig. 3A and C). As shown in the
microphotographs, magnification of the depicted area reveals
shortening of the dendritic length after glutamate exposure
(Fig. 3B and Videos S1 and S2).
Besides dendritic retraction and in agreement with Fig. 1A,
GFP-transfected neurons treated with glutamate (Fig. 4A show
that the classical continuous pattern observed in control projec-
tions became clearly discontinuous 3.5 h after glutamate treatment
(Fig. 4B and Videos S3 and S4).
PSA-NCAM decreases earlier than MAP-2 in response to
glutamate exposure
Having found that dendritic retraction occurred approximately
4 h after neuronal exposure to glutamate, we then studied PSA-
NCAM and MAP-2 immunorreactivity in adjacent time points,
ranging from 1 to 12 h. Three hours after glutamate treatment,
hippocampal neurons showed a decreased PSA-NCAM immuno-
staining that remained in lower values throughout the time points
studied (3–12 h) (Fig. 5A). Instead, MAP-2 immunorreactivity
reduction was not evident until 3 h later (6 h after glutamate
exposure), and remained low through the rest of the studied period
(12 h) (Fig. 5A). Quantification of total immunoreactive area for
PSA-NCAM and MAP-2 confirmed that glutamate-induced PSA-
NCAM reduction precedes the diminution in dendritic tree area
(Fig. 5B and C).
As described for total PSA-NCAM immunostaining (Fig. 5),
PSA-NCAM reduction was also detected at neuronal surface 3 h
after glutamate treatment. This effect lasted for at least 3 h and
was accompanied with a reduction in NCAM immunostaining
(Fig. 6A). Quantification of cell surface and total NCAM
immunoreactive area confirmed glutamate-induced PSA-NCAM
reduction at neuronal surface (Fig. 6B and C).
NCAM shows a different time pattern in connection with
glutamate-induced synapse remodeling and disassembly
Then, we studied glutamate-induced effects on NCAM and
SYN expression patterns over time (Fig. 7). Diminution in
individual NCAM puncta area became visible 1 h after glutamate
treatment and remained decreased for at least 3 h (Fig. 7A and D).
However, no changes were found in NCAM puncta number and
total NCAM puncta area during this same period (1–3 h) (Fig. 7A,
B and C). The same early pattern was observed for SYN; a
diminution in individual SYN puncta area with no changes in
SYN puncta number or total puncta area (Fig. 7A, B, C and D).
Six hours after glutamate exposure, opposite effects were found on
individual NCAM puncta area (Fig. 7A and D). On the other
hand, total NCAM puncta number and area decreased (Fig. 7A, B
and C). These effects lasted for at least 6 h. Synaptic SYN
expression showed the same pattern as described for NCAM
during this period (6–12 h), except for total SYN puncta area
reduction, which did not reach statistical significance until time
point 12 h after glutamate treatment (Fig. 7A, B, C and D).
The fPSA prevents glutamate-induced dendritic atrophy
and concomitant synapse remodeling
To test whether restoration of PSA actions would ameliorate the
effects of glutamate, we added a functional PSA mimetic peptide
(fPSA) immediately after glutamate treatment. fPSA prevented the
decrease of MAP-2 immunoreactivity (6 h) (Fig. 8A). Quantifica-
tion of MAP-2 immunoreactive area confirmed this result
(Fig. 8B).
In our experimental conditions, fPSA did not affect any of the
studied parameters in control conditions. While fPSA had no effect
on early glutamate-induced SYN and NCAM puncta changes,
particularly on the glutamate-induced individual puncta area
reduction (3 h), addition of this PSA mimetic peptide prevented
SYN and NCAM puncta changes that occurred 6 h after
glutamate treatment (Fig. 8C–F).
Discussion
It is well accepted that the hippocampus exhibits an impressive
capacity for structural reorganization. Granule neurons of the DG
and pyramidal neurons in areas CA3 and CA1 undergo dynamic
modifications in the form of dendritic extension and retraction, as
well as synapse formation and elimination. All of these types of
structural plasticity are subject to modification by a variety of
factors and conditions [1,2]. Not surprisingly, dysfunctional
structural plasticity in the form of reduced hippocampal volume,
primarily due to dendritic atrophy, has been associated to several
psychiatric and neurodegenerative disorders [6,38,39].
Herein, we demonstrate that a brief in vitro exposure of
hippocampal neurons to a low glutamate concentration is capable
of inducing dendritic atrophy in the absence of neuronal death, an
effect that proved to be NMDA receptor-mediated. Indeed, our
findings are in accordance with previous reports that show that in
Figure 7. Time-course of changes induced on NCAM and SYN synaptic patterns and levels by glutamate exposure. Hippocampal
neurons in culture (DIV 12–13) were briefly exposed to 5 mM glutamate and evaluated 1, 3, 6 and 12 h later. (A) Microphotographs of hippocampal
neurons in culture doubled stained for NCAM and SYN. (B) Synaptic puncta number, (C) total synaptic puncta area and (D) individual puncta area
were quantified for NCAM and SYN. Early decreases in individual NCAM and SYN puncta area precede the formation of larger NCAM and SYN clusters,
evidenced as increased individual puncta sizes. This latter effect was accompanied by a reduction in the number of puncta and total puncta area for
both NCAM and SYN. Results are expressed as mean values (6SEM) of 20–30 neurons per experimental condition. ns, non-significant; * P,0.05; ** P,
0.01; *** P,0.001 between bars, by Mann-Whitney test. Scale bars: 50 mm and 10 mm as magnification increases. NCAM: neural cell adhesion
molecule; SYN: synaptophysin.
doi:10.1371/journal.pone.0108921.g007
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vivo administration of glutamatergic antagonists prevents the
dendritic atrophy seen in chronic stress models [13,15,16].
Glutamate-induced dendritic retraction appears to be a gradual
phenomenon that progresses to dendritic atrophy. Having
determined that dendritic atrophy can be experimentally attained
in a relatively short time-lapse (4 h in culture), we further
investigated the earliest synaptic events, especially in connection
with cell adhesion molecules.
Hippocampal cell adhesion molecules, in particular NCAM,
which is one of the most abundant in excitatory synapses, are
known to participate in synapse formation and stability
[24,25,40,41] but also in synaptic plasticity [27,42]. PSA-NCAM
promotes synapse formation and remodeling [26,43]. Neverthe-
less, the role of the NCAM/PSA-NCAM balance in dendritic
atrophy remains largely unknown. Interestingly, the hippocampus
from NCAM (2/2) knockout mice is atrophic, notably in the
CA3 subfield and the DG. The atrophy appeared to be due to
reduced excrescence and loss of pyramidal cells in CA3, and
reduced branching and volume of granule cell dendrites in the DG
[44,45]. Similarly, stress-induced dendritic atrophy has been
associated to decreased NCAM hippocampal levels [46–50].
Although comparable results were obtained in our experimental
model 24 h after glutamate treatment, upon studying the time
course of early events we were able to determine that glutamate-
induced dendritic atrophy is not preceded by reduction in synaptic
NCAM levels. Our conclusion is based on the fact that the early
reduction in NCAM individual puncta size is not accompanied by
either decreased total NCAM puncta area or number. Instead, we
found a tendency towards an increase in the number of NCAM
puncta, which might indicate changes in the structure of the
puncta adherentia [51].
As regards PSA-NCAM, increased levels of this molecule have
been associated with synapse formation, neurite extension, repair
and plasticity [26,27,48,52–58]. Conversely, decreased PSA-
NCAM levels have been related to stress-induced cognition
deficits [59] and behavioral alterations in experimental depression
[60]. Therefore, PSA-NCAM is nowadays considered a marker of
structural synaptic remodeling [26,43]. Surprisingly, we show that
glutamate-induced dendritic atrophy is preceded by an important
early decrease in PSA-NCAM levels at the neuronal surface. It is
worth noting that PSA-NCAM levels can be down-regulated
through endocytosis in different cell types including neurons
[61,62], a regulatory step that may affect PSA-NCAM levels at the
plasma membrane.
Furthermore, it may be speculated that glutamate-induced
dendritic atrophy is a consequence of early changes in the
NCAM/PSA-NCAM balance. This imbalance would mainly
affect the PSA-NCAM mediated events that control repair and
promote neurite extension [51,52,55–57]. In accordance to this
hypothesis, recent reports have described structural remodeling of
hippocampal dendritic spines after PSA removal from NCAM
[28] as well as changes in PSA-NCAM that parallel to dendritic
retraction of amygdaloid interneurons after chronic stress [63].
Interestingly, we found a diminution in the number of synapses
that occurs concomitantly with dendritic atrophy, as seen by the
decreased puncta number and total puncta area for NCAM and
SYN. These changes are accompanied by larger clusters of
NCAM and SYN. The reported observations may well be the
result of synaptic disassembly or endocytic transport processes. In
fact, it is known that NCAM participates in the recruitment of the
synaptic vesicle pool [24,25] and that mono-ubiquitine is the signal
that triggers its clathrin-dependent internalization [61,64]. There-
fore, our results depict a mechanism by which glutamate-
dependent synaptic remodeling progresses to dendritic atrophy
and synapse loss. Herein, we show that dendritic atrophy and
synapse remodeling/disassembly are prevented by a fPSA,
suggesting a PSA role in functional aspects of these processes.
Moreover, our findings suggest that synaptic loss requires a
reduction in PSA-NCAM as previously shown [26], but also
implies changes in NCAM synaptic pattern and levels. The fact
that PSA-NCAM has been shown to inhibit GluN2B-containing
NMDA receptors at low glutamate concentrations [65,66] may
account for an enhanced NMDA-mediated glutamate response in
Figure 8. A functional PSA mimetic peptide (fPSA) prevents glutamate-induced MAP-2 decrease and concomitant changes in SYN
and NCAM synaptic patterns and levels. Hippocampal neurons in culture (DIV 12–13) were briefly exposed to 5 mM glutamate, immediately
treated with fPSA and evaluated 3 and 6 h later. (A) Microphotographs of hippocampal neurons in culture stained for MAP-2. (B) Quantification of
MAP-2 immunoreactive area showed decreased levels 6 h after glutamate exposure; this decrease was prevented by fPSA. (C) Microphotographs of
neurons double stained for SYN and NCAM. (D) Synaptic puncta number, (E) total synaptic puncta area and (F) individual puncta area were quantified
for SYN and NCAM. The fPSA did not prevent early decrease in individual NCAM and SYN puncta area (3 h) but did prevent SYN and NCAM puncta
changes seen 6 h after glutamate treatment. Results are expressed as mean values (6SEM) of 20–30 neurons per experimental condition. * P,0.05; **
P,0.01; *** P,0.001 between bars, by Mann-Whitney test. #P,0.05; ## P,0.01; ### P,0.001 between bars, two-way ANOVA followed by
Bonferroni test. Scale bars: 50 mm. fPSA: functional PSA mimetic peptide; MAP-2: microtubule-associated protein 2; NCAM: neural cell adhesion
molecule; SYN: synaptophysin.
doi:10.1371/journal.pone.0108921.g008
Figure 9. Schematic representation of glutamate induced
changes on dendritic atrophy, NCAM and synaptic markers.
Temporal course of changes induced by glutamate exposure reveals
that NCAM-synaptic reorganization occurs soon after the insult and
prior to the decrease in PSA-NCAM levels. Thereafter, dendritic atrophy,
established 4 h after treatment, is followed by reductions in SYN and
NCAM cluster number, which indicates synapse loss.
doi:10.1371/journal.pone.0108921.g009
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a low PSA-NCAM condition such as the one found in our
experimental model. It is noteworthy that PSA exerts a similar
GluN2B-containing NMDA receptor inhibition. This effect has
been proposed to be independent of the PSA carrier protein and to
involve a direct or indirect action on this type of NMDA receptors
[65]. Taking also into account that Torregrossa et al. (2004) [32]
have suggested that fPSA adopts a conformation that mimics the
PSA antigenic structure, it could be thought that a direct or
indirect interaction of fPSA with GluN2B-containing NMDA
receptors might take place in our conditions.
To sum up, our findings suggest that glutamate-dependent
synaptic remodeling ultimately leads to dendritic atrophy and
synapse loss. Moreover, they shed light on the time course of early
events: while PSA-NCAM level diminution and NCAM-synaptic
reorganization precede dendritic atrophy, synaptic-associated
NCAM reduction is a delayed event related to synapse disassembly
(Fig. 9). To our knowledge this is the first in vitro study to support
the notion that distinctive stages in PSA-NCAM/NCAM balance
accompany glutamate-induced dendritic atrophy and synapse loss.
Not only altered PSA-NCAM levels have been reported in
depression, schizophrenia and neurodegenerative disorders
[60,67–70], but also diminished NCAM levels were evidenced in
some of these pathologies and in animal models of these diseases
[45–49,71,72]. Hippocampal atrophy precedes synaptic and
neuronal loss in a sequence of changes that could indicate
different stages in the progression of the disease [37,38,73].
Therefore, it could be speculated that prevention or reversion of
glutamate-induced atrophy could result in a successful early
intervention. Further studies are required to shed light on the role
of PSA-NCAM/NCAM balance in the prevention or reversion of
brain pathologies that imply structural changes involving dendritic
atrophy and synapse loss.
Supporting Information
Video S1 Glutamate-induced dendritic retraction visu-
alized in CMFDA-stained neurons. Hippocampal neurons in
culture (DIV 12–13) were stained with the CMFDA dye and then
briefly exposed to 5 mM glutamate, and live-imaged 2 h later
every 5 min for a 3 h-period. Time-lapse series of control
hippocampal living neurons in culture showing the normal
progress of dendritic outgrowth and retraction in CMFDA
positive neurites.
(WMV)
Video S2 Glutamate-induced dendritic retraction visu-
alized in CMFDA-stained neurons. Hippocampal neurons in
culture (DIV 12–13) were stained with the CMFDA dye and then
briefly exposed to 5 mM glutamate, and live-imaged 2 h later
every 5 min for a 3 h-period. Time-lapse series of glutamate-
treated hippocampal living neurons in culture showing the
progressive shortening of CMFDA positive neurites.
(WMV)
Video S3 A continuous projection pattern becomes
discontinuous after glutamate exposure. GFP-transfected
hippocampal neurons in culture (DIV 12–13) were briefly exposed
to 5 mM glutamate and live-imaged 2 h later every 5 min for a
3 h-period. Time-lapse series of control hippocampal living
neurons in culture showing the normal continuous projection
pattern.
(WMV)
Video S4 A continuous projection pattern becomes
discontinuous after glutamate exposure. GFP-transfected
hippocampal neurons in culture (DIV 12–13) were briefly exposed
to 5 mM glutamate and live-imaged 2 h later every 5 min for a
3 h-period. Time-lapse series of glutamate-treated hippocampal
living neurons in culture showing the progression from a normal
continuous pattern into a discontinuous one.
(WMV)
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